Lisata Therapeutics CEO David Mazzo on ASCEND and iLSTA trial results

By Proactive Investors / January 23, 2025 / www.youtube.com / Article Link

Lisata Therapeutics Inc (NASDAQ:LSTA) CEO David Mazzo joined Proactive's Stephen Gunnion with an update on the company's ...

Recent News

Gold stocks outperform equities surge

May 11, 2026 / www.canadianminingreport.com

Global tech once again leading the markets in 2026

May 11, 2026 / www.canadianminingreport.com

Strong Q1/26 results continue with Agnico, Kinross and Alamos reporting

May 04, 2026 / www.canadianminingreport.com

Gold stocks decline as equities reach all-time highs

May 04, 2026 / www.canadianminingreport.com

Gold stocks decline on metal pullback

April 27, 2026 / www.canadianminingreport.com

See all >